Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-02-15 | Dr. Robert D. AllenChief Scientific Officer | 61,42k | 0,00 | Derivative Exercise and Retained Stock | - | 114,49k | 115,74% |
| 2026-02-15 | Dr. Robert D. AllenChief Scientific Officer | -37,58k | 58,60k | Derivative Exercise and Sale | 1,54 - 1,58 | 114,49k | - |
| 2026-02-15 | Ms. Julie GreenChief HR Officer | 58,37k | 0,00 | Derivative Exercise and Retained Stock | - | 107,72k | 118,30% |
| 2026-02-15 | Ms. Julie GreenChief HR Officer | -40,63k | 63,35k | Derivative Exercise and Sale | 1,54 - 1,58 | 107,72k | - |
| 2026-02-15 | Mr. William E. DukeCFO, Principal Accounting Officer & Principal Executive Officer | 58,37k | 0,00 | Derivative Exercise and Retained Stock | - | 107,72k | 118,30% |
| 2026-02-15 | Mr. William E. DukeCFO, Principal Accounting Officer & Principal Executive Officer | -40,63k | 63,35k | Derivative Exercise and Sale | 1,54 - 1,58 | 107,72k | - |
| 2026-02-15 | Mr. Timothy LeeChief Commercial Officer | 58,37k | 0,00 | Derivative Exercise and Retained Stock | - | 117,72k | 98,36% |
| 2026-02-15 | Mr. Timothy LeeChief Commercial Officer | -40,63k | 63,35k | Derivative Exercise and Sale | 1,54 - 1,58 | 117,72k | - |
| 2026-02-15 | Ms. Jill AndersenChief Legal Officer & Corporate Secretary | 97,29k | 0,00 | Derivative Exercise and Retained Stock | - | 182,24k | 114,53% |
| 2026-02-15 | Ms. Jill AndersenChief Legal Officer & Corporate Secretary | -67,71k | 105,58k | Derivative Exercise and Sale | 1,54 - 1,58 | 182,24k | - |
| 2025-12-23 | Adimab, LLCUnternehmen | -192,32k | 577,50k | Verkauf | 3,00 | 20,26M | -0,94% |
| 2025-11-19 | Mr. Kevin F. McLaughlinIndependent Director | 50,00k | 125,00k | Kauf | 2,50 | 50,00k | - |
| 2025-11-17 | Adimab, LLCUnternehmen | -1,23M | 3,70M | Verkauf | 3,00 | 20,45M | -5,69% |
| 2025-08-15 | Mr. Timothy LeeChief Commercial Officer | 49,34k | 0,00 | Derivative Exercise and Retained Stock | - | 59,34k | 493,44% |
| 2025-08-15 | Mr. Timothy LeeChief Commercial Officer | -49,66k | 29,81k | Derivative Exercise and Sale | 0,57 - 0,65 | 59,34k | - |
| 2025-08-15 | Mr. William E. DukeCFO, Principal Accounting Officer & Principal Executive Officer | -49,66k | 29,81k | Derivative Exercise and Sale | 0,57 - 0,65 | 49,34k | - |
| 2025-08-15 | Mr. William E. DukeCFO, Principal Accounting Officer & Principal Executive Officer | 49,34k | 0,00 | Derivative Exercise and Retained Stock | - | 49,34k | - |
| 2025-08-15 | Ms. Julie GreenChief HR Officer | 49,34k | 0,00 | Derivative Exercise and Retained Stock | - | 49,34k | - |
| 2025-08-15 | Ms. Julie GreenChief HR Officer | -49,66k | 29,81k | Derivative Exercise and Sale | 0,57 - 0,65 | 49,34k | - |
| 2025-08-15 | Ms. Jill AndersenChief Legal Officer & Corporate Secretary | 82,25k | 0,00 | Derivative Exercise and Retained Stock | - | 84,95k | 3.046,15% |
| 2025-08-15 | Ms. Jill AndersenChief Legal Officer & Corporate Secretary | -82,75k | 49,68k | Derivative Exercise and Sale | 0,57 - 0,65 | 84,95k | - |
| 2025-08-15 | Dr. Robert D. AllenChief Scientific Officer | 53,07k | 0,00 | Derivative Exercise and Retained Stock | - | 53,07k | - |
| 2025-08-15 | Dr. Robert D. AllenChief Scientific Officer | -45,93k | 27,57k | Derivative Exercise and Sale | 0,57 - 0,65 | 53,07k | - |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
